ストックスクリーナーアプリを入手
346.07
0.10%
-0.35
前日終値:
$346.42
開ける：
$345.19
24時間の取引高:
112.30K
Relative Volume:
0.40
時価総額：
$38.30B
収益：
$4.98B
当期純損益:
$69.60M
株価収益率:
665.78
EPS:
0.5198
ネットキャッシュフロー:
$525.67M
1週間 パフォーマンス:
-2.22%
1か月 パフォーマンス:
-1.42%
6か月 パフォーマンス:
+12.54%
1年 パフォーマンス:
+53.47%
1日の値動き範囲:
$345.19
$352.18
1週間の範囲:
$342.00
$358.38
52週間の値動き範囲:
$196.45
$385.22
Beone Medicines Ltd Adr Stock (ONC) Company Profile
名前
Beone Medicines Ltd Adr
セクター
電話
41-616851900
住所
C/O BEONE MEDICINES I GMBH, BASEL
Compare ONC vs VRTX, REGN, ARGX, ALNY
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
Beone Medicines Ltd Adr Stock (ONC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-24 | 開始されました | Truist | Buy |
| 2025-09-18 | 開始されました | Barclays | Overweight |
| 2025-04-07 | 開始されました | RBC Capital Mkts | Outperform |
| 2025-03-03 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-12-03 | 再開されました | Morgan Stanley | Overweight |
| 2024-09-18 | 開始されました | JMP Securities | Mkt Outperform |
| 2024-02-06 | 再開されました | JP Morgan | Overweight |
| 2023-09-12 | 開始されました | Macquarie | Outperform |
| 2023-08-17 | 開始されました | Jefferies | Buy |
| 2023-07-17 | 開始されました | Citigroup | Buy |
| 2023-06-30 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2023-01-12 | 開始されました | Daiwa Securities | Buy |
| 2022-10-13 | アップグレード | Guggenheim | Neutral → Buy |
| 2022-10-13 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2022-08-09 | 再開されました | JP Morgan | Overweight |
| 2022-03-17 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2022-02-07 | 開始されました | Deutsche Bank | Buy |
| 2021-10-12 | 開始されました | Bernstein | Outperform |
| 2021-10-06 | アップグレード | CLSA | Underperform → Buy |
| 2021-03-08 | 開始されました | China Renaissance | Buy |
| 2021-03-01 | ダウングレード | CLSA | Outperform → Underperform |
| 2020-11-09 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2020-11-06 | ダウングレード | Maxim Group | Buy → Hold |
| 2020-11-06 | ダウングレード | Piper Sandler | Neutral → Underweight |
すべてを表示
Beone Medicines Ltd Adr (ONC) 最新ニュース
M&G PLC Has $41.17 Million Holdings in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
ABN Amro Investment Solutions Lowers Holdings in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Bernstein Remains a Buy on BeOne Medicines AG (ONC) - Finviz
Zymeworks To Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 2, 2026 - GlobeNewswire Inc.
Candriam S.C.A. Sells 67,718 Shares of BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Chan Henry Lee Sells 1,660 Shares of BeOne Medicines (NASDAQ:ONC) Stock - MarketBeat
BeOne Medicines Trial Wins And Sonrotoclax Clearance Meet Valuation Discount - Sahm
BeOne Medicines Ltd.Sponsored ADR (NASDAQ:ONC) Sees Significant Decline in Short Interest - MarketBeat
3 Stocks to Buy in February - Finviz
Wall Street Bullish on BeOne Medicines AG (ONC) amid Robust Pipeline Development - Finviz
Mirae Asset Global Investments Co. Ltd. Acquires 38,992 Shares of BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Citizens Highlights BeOne Medicines' (ONC) $3.8B Revenue Potential for 2025 - Finviz
BeOne Medicines Collaboration Extends Safety Modeling As Shares Trade Below Targets - Sahm
Assessing BeOne Medicines (ONC) Valuation After Expanded InSysBio Collaboration On Clinical Trial Modeling - Sahm
Did BeOne’s New Uptrend And Upgraded Earnings Outlook Just Shift Its (ONC) Investment Narrative? - simplywall.st
BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
EMCOR Group, Inc. (NYSE:EME) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
Financial Review: Atossa Genetics (NASDAQ:ATOS) versus ADM Tronics Unlimited (OTCMKTS:ADMT) - Defense World
BeOne Medicines (NASDAQ:ONC) Shares Gap DownShould You Sell? - MarketBeat
BeOne Medicines Earnings Momentum Spurs Valuation Debate And Analyst Optimism - Sahm
Five Below Upgraded, Spotify Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
BEONE MEDICINES LTD-ADR (NASDAQ:ONC) Passes Minervini Trend Template and Strong Growth Scan - ChartMill
CICC Predicts HSI to Add ZIJIN GOLD INTL/ BEONE MEDICINES/ PICC P&C/ AKESO as New Constituents; STANCHART May Replace HANG SENG BANK - AASTOCKS.com
Assessing BeOne Medicines (ONC) Valuation After A Year Of Strong Shareholder Returns - Sahm
HERIZON-GEA-01 Phase 3 Zanidatamab Combo Data Might Change The Case For Investing In BeOne Medicines (ONC) - Sahm
Chan Henry Lee Sells 664 Shares of BeOne Medicines (NASDAQ:ONC) Stock - Defense World
JGP Global Gestao de Recursos Ltda. Decreases Stock Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Fingerlakes Wealth Management Inc. Has $6.96 Million Holdings in Schwab U.S. Large-Cap Growth ETF $SCHG - Defense World
BeOne Medicines (NASDAQ:ONC) SVP Chan Henry Lee Sells 664 Shares - MarketBeat
Snowline Gold (CVE:SGD) Shares Up 3% – Here’s What Happened - Defense World
Is the Options Market Predicting a Spike in BeOne Medicines Stock? - Yahoo Finance
BrightSpire Capital (NYSE:BRSP) Shares Gap Down – Here’s What Happened - Defense World
BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Voya Investment Management LLC Raises Holdings in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
John Oyler Sells 75,631 Shares of BeOne Medicines (NASDAQ:ONC) Stock - Defense World
BeOne Medicines appoints Dr. Lai Wang as president and global head of R&D - Investing.com
BeOne Medicines (NASDAQ:ONC) CEO John Oyler Sells 24,369 Shares - MarketBeat
BeOne Medicines (NASDAQ:ONC) Shares Gap Down After Insider Selling - Defense World
BeOne Medicines (NASDAQ:ONC) Shares Gap Down Following Insider Selling - MarketBeat
Ford Upgraded, Amazon Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
LMR Partners LLP Acquires New Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
China Universal Asset Management Co. Ltd. Makes New Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines (NASDAQ:ONC) SVP Sells $107,900.00 in Stock - MarketBeat
35,910 Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC Purchased by Axa S.A. - Defense World
Bellevue Group AG Makes New $9.37 Million Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
35,910 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Purchased by Axa S.A. - MarketBeat
Lee Chan Henry, SVP at BeOne Medicines, sells shares worth $213,568 - Investing.com
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases Shares of 9,377 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
12,338 Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC Purchased by American Century Companies Inc. - Defense World
Beone Medicines Ltd Adr (ONC) 財務データ
収益
当期純利益
現金流量
EPS
Beone Medicines Ltd Adr (ONC) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Lee Chan Henry | SVP, General Counsel |
Feb 04 '26 |
Sale |
349.52 |
1,660 |
580,197 |
0 |
1.92%
1.39%
大文字化:
|
ボリューム (24 時間):